Evidence map›Paper›PMID 29187233›Full record

ArticleMalaria journal2017

Identification of O-GlcNAcylated proteins in Plasmodium falciparum.

Mattis Kupferschmid, Moyira Osny Aquino-Gil, Hosam Shams-Eldin, Jörg Schmidt, Nao Yamakawa, Frédéric Krzewinski, Ralph T Schwarz, Tony Lefebvre

Abstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Investigation of carbohydrate-based molecules ofFrontiers in veterinary science · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Targeting plasmodium α-tubulin-1 to block malaria transmission to mosquitoes.Frontiers in cellular and infection microbiology · 2023
    Article
  9. Article
  10. Article
  11. Mass Spectrometry for O-GlcNAcylation.Frontiers in chemistry · 2021
    Review
  12. Unveiling the Sugary Secrets ofFrontiers in microbiology · 2021
    Review
  13. Article
  14. ProteinParasitology · 2019
    Review
  15. Article
  16. Identification ofFrontiers in endocrinology · 2019
    Article
  17. Review
  18. Review
  19. Facile Preparation ofMolecules (Basel, Switzerland) · 2018
    Article
  20. Apart From Rhoptries, Identification ofFrontiers in endocrinology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mattis KupferschmidInstitute for Virology, Laboratory of Parasitology, Philipps-University, Marburg, Germany.
Moyira Osny Aquino-GilUniv. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France.
Hosam Shams-EldinInstitute for Virology, Laboratory of Parasitology, Philipps-University, Marburg, Germany.
Jörg SchmidtInstitute for Virology, Laboratory of Parasitology, Philipps-University, Marburg, Germany.
Nao YamakawaUniv. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France.
Frédéric KrzewinskiUniv. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France.
Ralph T SchwarzInstitute for Virology, Laboratory of Parasitology, Philipps-University, Marburg, Germany.
Tony LefebvreUniv. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France. tony.lefebvre@univ-lille1.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-translational modifications (PTMs) constitute a huge group of chemical modifications increasing the complexity of the proteomes of living beings. PTMs have been discussed as potential anti-malarial drug targets due to their involvement in many cell processes. O-GlcNAcylation is a widespread PTM found in different organisms including Plasmodium falciparum. The aim of this study was to identify O-GlcNAcylated proteins of P. falciparum, to learn more about the modification process and to understand its eventual functions in the Apicomplexans.

methodsThe P. falciparum strain 3D7 was amplified in erythrocytes and purified. The proteome was checked for O-GlcNAcylation using different methods. The level of UDP-GlcNAc, the donor of the sugar moiety for O-GlcNAcylation processes, was measured using high-pH anion exchange chromatography. O-GlcNAcylated proteins were enriched and purified utilizing either click chemistry labelling or adsorption on succinyl-wheat germ agglutinin beads. Proteins were then identified by mass-spectrometry (nano-LC MS/MS).

resultsWhile low when compared to MRC5 control cells, P. falciparum disposes of its own pool of UDP-GlcNAc. By using proteomics methods, 13 O-GlcNAcylated proteins were unambiguously identified (11 by click-chemistry and 6 by sWGA-beads enrichment; 4 being identified by the 2 approaches) in late trophozoites. These proteins are all part of pathways, functions and structures important for the parasite survival. By probing clicked-proteins with specific antibodies, Hsp70 and α-tubulin were identified as P. falciparum O-GlcNAc-bearing proteins.

conclusionsThis study is the first report on the identity of P. falciparum O-GlcNAcylated proteins. While the parasite O-GlcNAcome seems close to those of other species, the structural differences exhibited by the proteomes provides a glimpse of innovative therapeutic paths to fight malaria. Blocking biosynthesis of UDP-GlcNAc in the parasites is another promising option to reduce Plasmodium life cycle.

Indexed as

Protein Processing, Post-TranslationalProteomeAcetylglucosamineGlycosylationPlasmodium falciparumProtozoan ProteinsAcetylglucosaminepoly-N-acetyl glucosamineProteomeProtozoan ProteinsGlycolysisHsp70O-GlcNAcylationPlasmodium falciparumProteomicsα-Tubulin

Identifiers

PMID29187233
PMCPMC5707832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.